(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
US-RE50497-E · Jul 22, 2025 · US
This page is not indexed by search engines while we improve data quality.
Whitney James Andrew patents
Whitney James Andrew is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Whitney James Andrew |
| Total patents | 8 |
| First publication | May 28, 2015 |
| Latest publication | Jul 22, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Treatment of acvr1-mediated diseases
US-2018042933-A1 · Feb 15, 2018 · US
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
US-9809559-B2 · Nov 7, 2017 · US
(n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
US-2016347719-A1 · Dec 1, 2016 · US
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
US-9469613-B2 · Oct 18, 2016 · US
Therapies for treating myeloproliferative disorders
US-2016279135-A1 · Sep 29, 2016 · US
(n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
US-2015361050-A1 · Dec 17, 2015 · US
Therapies for treating myeloproliferative disorders
US-2015148345-A1 · May 28, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Gilead Sciences Inc | 7 |
| Glaxosmithkline Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| A61P43/00 | 8 |
| A61K31/5377 | 8 |
| A61P7/00 | 7 |
| A61P35/02 | 7 |